The NSW Branch has designed a major event to bring CPD closer to pharmacists living and working in regional NSW. The NSW Pharmacy in Focus program provides education that is current and relevant to pharmacists wherever they work. Local and guest speakers will share their knowledge and expertise and there will plenty of opportunities to meet and catch up with pharmacists near and far.
In the second half of this year the NSW Pharmacy in Focus program will have a focus on cardiovascular disease. A range of topics including heart failure, hypertension, atrial fibrillation, ischaemic heart disease and managing risk factors such as diabetes, smoking and obesity. (Not all topics will be covered at each event)
The program includes two member benefit programs that can earn you up to 8 Group 2 CPD credits.
Bridging the Gap: A workshop designed to put the patient at the centre of care and helps identify and address factors that are barriers to maintaining continuity of care in the transition between care settings. The workshop is FREE for PSA and SHPA members.
Better Pharmacy Futures Forum: A member only forum aiming to assist community pharmacists better understand the environment in which they are working and offer practical ideas on how to thrive, not just survive.
Saturday 20 September: 1.00pm – 8.30pm
Sunday 21 September: 8.30am-4.30pm
Accredited for up to 24 Group 2 CPD credits
Sebel Harbourside Kiama, NSW
Session 1: BTG – A case study workshop and interactive discussion forum that looks at how pharmacists can bridge the Gap in communication between health sectors to provide better, more patient-centred continuity of care.
Session 2: Hands on devices workshop – Proper use and understanding of devices to screen for, prevent and monitor cardiovascular risk and associated comorbidities can play a significant role in the management of risk and the progression of disease. This workshop will provide practical demonstration and hands on instructions for the use of blood glucose meters, insulin pens and blood pressure monitors including nationally recognised guidelines for appropriate assessment and intervention.
Session 3: BPFF – A forum to share methods and ideas which further the business success of community pharmacies, as well as assisting PSA in how to best meet the needs of members involved in community pharmacy business.
Day 2: A clinical update on heart failure, and alternative and complementary medicines for heart health; a chronic disease management workshop looking at cardiovascular risk reduction in chronic kidney disease and diabetes and an interactive session demonstrating how pharmacists can work collaboratively with other health care professionals to improve patient outcomes by raising awareness of specialist services and referral pathways.
- Understand issues relating to the continuity of care when patients transition between care settings
- Acquire skills to improve pharmacists’ ability to demonstrate the correct use of medical devices for screening, monitoring and prevention
- Raise awareness of pharmacists’ changing profession and the need for innovation and implementation of new models for advancing and sustaining the profession.
- Understand issues related to the care of patients at risk of or with cardiovascular disease
Bridging the Gap
The Bridging the Gap (BTG) workshop brings together pharmacists with hospital, accredited and community backgrounds, to discuss how we can work together to provide better and more patient centred continuity of care. The group will share information and experiences, to develop pathways and models of care for patients with special needs or transitioning between care settings.
BTG – Hospital and community medication management
- Update on a clinical condition and therapeutic treatments that are part of a medical profile for a patient referred for a medication review
- Discuss treatment guidelines for medical conditions that present in a medication review case
- Analyse the medication profile and factors that may impact on the optimal health outcomes for the patient
- Identify communication barriers between all involved in the medicines – management pathway and explore potential solutions
Hands on devices – screening, prevention and monitoring
Proper use and understanding of devices to screen for, prevent and monitor cardiovascular risk and associated co-morbidities can play a significant role in the management of risk and the progression of disease. This workshop will provide practical demonstration and hands on instructions for the use of blood glucose meters, insulin pens and blood pressure monitors including nationally recognised guidelines for appropriate assessment and intervention.
- Discuss the use of devices to screen, monitor and prevent disease
- Understand the purpose for monitoring blood glucose and the advantages and disadvantages
- Analyse patient’s data to make a systematic assessment for daily and long term management of blood glucose
- Trouble shoot issues associated with the use of blood glucose meters
- Demonstrate the appropriate use of a variety of insulin injecting devices
- Understand how screening for hypertension can impact on the risk of developing cardiovascular disease
- Learn how to use blood pressure monitors and how to measure blood pressure according to Heart Foundation guidelines
Better Pharmacy Futures Forum
- Assist community pharmacists to better understand the environment in which they are working and offer practical solutions on how to thrive, not just survive
- Work with Medicare Locals to identify priority health needs of their community and to develop practical strategies and programs which can be implemented locally to meet these needs
- Have your say on how PSA can advance the following key issues for action: fee for service; bridging the gap and pharmacies as health care destinations
- Nominate key issues to be proposed to local Members of Parliament in the lead up to the 2015 NSW election
People with atrial fibrillation are at increased risk of stroke. This session covers the physiology of atrial fibrillation, its treatment and how stroke risk is assessed to guide antithrombotic treatment. The differences in antithrombotic treatments and their modes of action will be explained and compared in terms of efficacy and safety
- Explain atrial fibrillation, treatment and management in terms of stroke prevention
- Compare the overall efficacy and safety of current treatment options in SPAF
- Recognise the roles of warfarin and novel anticoagulants
Advanced care planning for heart failure patients
People with heart failure have a chronic debilitating disease which can have a major impact on quality of life. Management of heart failure not only involves managing medications and disease progression, but includes non-pharmacotherapeutic measures to provide symptomatic relief and palliative care.
- Update on the causes, types and symptoms of heart failure
- Review pharmacotherapeutic treatment options for patients with heart failure
- Understand the importance on non- pharmacotherapeutic measures to provide symptomatic relief and manage the progression of heart failure.
- Increase knowledge of treatment protocols for medicines used in the palliative care of people with heart failure
- Describe the role of the pharmacist in advanced care planning for heart failure patients and support for their carers
Acute coronary syndrome and secondary prevention
Acute coronary syndrome (ACS) refers to any group of symptoms attributed to obstruction of the coronary arteries. ACS usually occurs as a result of one of three problems. Although signs and symptoms may be similar, acute treatment differs according to the source of the problem. Pharmacists can provide pharmacological and non-pharmacological intervention and post event recommendations for secondary prevention.
- Define acute coronary syndrome
- Describe usual treatments for the 3 main types of acute events, variations and duration
- Develop an understanding of the importance of non pharmacological interventions and the benefit of cardiac rehabilitation
- Describe services that are available for cardiac rehabilitation and other resources for secondary prevention.
Cardiovascular risk reduction in CKD
Chronic kidney disease (CKD) is an independent and highly significant risk factor for cardiovascular disease. By improving self-management of CKD we aim to prevent avoidable admissions to hospital and support patients to improve quality of life.
Chronic disease management workshop – Cardiovascular risk reduction in CKD and diabetes.
- Identify the risk factors associated with CKD and cardiovascular risk
- Understand the relationship between kidney function and absolute cardiovascular risk
- Highlight the differences a CKD diagnosis will make to the management strategies, treatment targets and therapy choices for patients
- Describe self-management options for chronic conditions that can help people stay well and improve quality of life
- Describe how pharmacists can play a role in chronic disease management in a multidisciplinary team
Collaborative care – Managing lifestyle risk factors for cardiovascular disease
Cardiovascular risk includes modifiable and non-modifiable factors. Most modifiable risk factors entail lifestyle changes that require motivation and perseverance. There are many approaches to smoking cessation, changing diet, reducing weight and increasing exercise, all with evidence of success. It is important that health professionals work as a team and puts the patient at the centre of care to support their attempts to manage CV risk.
- Understand the impact of modifiable and non-modifiable risk factors on the development and progression of cardiovascular disease
- Describe motivational interviewing techniques to facilitate positive changes to reduce risk and improve health
- Get an insight into the expertise provided by specialist health professionals to support people with cardiovascular risk factors such as, smoking, overweight and obesity, poor nutrition and lack of exercise.
- Describe collaborative pathways with allied health professionals to help manage lifestyle risk factors for cardiovascular disease
- Develop systems and protocols for referring patients for specialised treatment and advice.
- Highlight the key lifestyle factors impacting on CV disease – nutrition, stress, exercise, smoking, alcohol
- Highlight the main evidence based recommendations for managing CV disease
- Discuss practical ‘take home points’ for pharmacists to use in any clinical encounter
- Discuss referral options – a multidisciplinary approach
Behaviour change section:
- The problem of non adherence
- Identifying our role as practitioners – is it more than just prescribing and educating??
- Understanding readiness to change – practical strategies to increase readiness, importance and confidence
Competency standards assigned
1.1 Practice legally
1.2 Practice to accepted standards
1.3 Deliver ‘patient-centred’ care
1.4 Manage quality and safety
2.1 Communicate effectively
2.3 collaborate with members of the health care team
3.1 Provide leadership and organizational planning
3.2 Manage and develop personnel
4.2 Consider the appropriateness of prescribed medicines
6.1 Assess primary health care needs
6.2 Deliver primary healthcare
6.3 Contribute to public and preventive health
7.1 Contribute to therapeutic decision-making
7.2 Provide ongoing medication management
7.3 Influence patterns of medicine use